>>168845
ozempic only targets one receptor, and it does so aggressively. it mainly slows gastric emptying with some effects on insulin sensitivity and inflammation.

mounjaro adds a second target receptor, which increases lipid release from adipocytes. this tends to increase speed of fat loss from unhealthy tissues in particular.

the new main drug retatrutide adds a third target receptor, along with dramatic improvements to its effects on the second receptor. it increases your base metabolism substantially, increases fat freeing from adipose, and theres reports that even holding your body weight on it can produce substantial changes in body composition from these effects. its reported as being able to cure fatty liver disease within 3-6 months of treatment.

we are seriously underestimating the significance of these medications as a culture for our overall health, particularly as we age. type 2 diabetes might well be eradicated.